Cardio ‘017 – The Hotel - 13-05-2017
Michel P. HERMANS
MD (UCL) PhD (UCL & Oxford, UK) Dip. Natural Sciences (Open University, Milton Keynes, UK) Dip. Earth Sciences (Open University, Milton Keynes, UK)
Dip. Human Geography (Open University, Milton Keynes, UK) Dip. Environment (Open University, Milton Keynes, UK)
PG Certificate in Social Sciences (Open University, Milton Keynes, UK)
Endocrinologie&Nutri0onCliniquesuniversitairesSt-Luc
UniversitéCatholiquedeLouvain
Olea europaea in hypertension & metabolic syndrome
1. Hypertension & endothelial dysfunction 2. Tensiofytol® : composition & MOA 3. Metabolic syndrome 4. Efficacy studies 5. PREDIMED study 6. Patient’s profile & ongoing study
Physiopathology of Hypertension
Endothelial dysfunction causes hypertension
Constriction
é Vascular Resistance
When the diameter of the artery diminishes, the blood pressure increases
The blood pressure is the pressure of circulating blood on the walls of the arteries, it depends on the flexibility and the size of the arteries
Flexible blood vessel (dilatation & vasoconstriction)
Rigid blood vessel (endothelial dysfunction)
Endothelium
´ The vascular endothelium is the inner layer (monocellular) of the blood vessels, the one in contact with the blood.
´ Functions:
´ Keeps the blood inside the blood vessels
´ Regulation of the vascular permeability
´ Molecular filter (exchange of nutrients)
´ Regulation of the interaction between the vessel wall / leucocytes, platelets
´ Regulation of the vasomotion: can liberate nitric oxide(NO) which provokes vasodilatation
´ The major cardiovascular pathologies like atherosclerosis, hypertension, diabetes are characterized by the dysfunction of the endothelial cells (often oxidative stress) with a reduction of the dependant relaxations of the endothelium.
Endo- thelium
Smooth Muscle
cells
Control: • Only 3 out of 10 patients with antihypertensive treatments1 are monitored on the
target values (<140/90 mmHg)
• > 2, the number of antihypertensive drugs needed to reach the target BP, in most of the clinical studies
Low treatment compliance (bad adherence to treatment): § Side effects/ cost of treatment / dosage § 1 patient out of 2 stops the antihypertensive treatment after 3 years2
§ Only 1 patient out of 5 resorting to specialized medical care for a resistant hypertension has been found to take all prescribed medicines during a test held in the Netherlands (Sympathy Study).
Poorly-controlled Hypertension
1. Wolf-Maier et al. 2004 2. Van Wijk et al. 2005
Badly controlled hypertension increases the risk of stroke, myocardial infarctions, auricular fibrillation, heart failure or kidney disease
1. Hypertension & endothelial dysfunction 2. Tensiofytol® : composition & MOA 3. Metabolic syndrome 4. Efficacy studies 5. PREDIMED study 6. Patient’s profile & ongoing study
Daily dose 2 capsules:
´ 334mg standardized olive leaf extract à 100mg oleuropein +
´ EFSA: helps maintaining a normal blood pressure
´ 106mg standardized olive extract à 20mg hydroxytyrosol ´ EFSA: contributes to decreasing the oxidation of LDL cholesterol
IMPROVES THE
THE BLOOD PRESSURE
ENDOTHELIAL FUNCTION AND DECREASES
RECOMMENDED USE From 18 years :
2 capsules per day
The first in the morning before breakfast
and the second in the evening with a large glass of water
Active ingredients & metabolism
Unique composition
´ The best of 2 parts of the plant
´ LEAF: Extract standardized in Oleuropein +
´ FRUIT: Extract standardized in Hydroxytyrosol
´ Oleuropein metabolizes à Hydroxytyrosol + other active metabolites
´ Hydroxytyrosol immediately available through the fruit extract
+ Active substances in the extracts: phenolic derivatives, triterpenes (oleanolic acid)
´ Fast and effective action, maximum concentrations after
´ 2h for Oleuropein
Tensiofytol Mode of action
Flexible blood vessel (dilatation & vasoconstriction)
Rigid blood vessel (endothelial dysfunction)
Oleuropein & Hydroxytyrosol
Treatment of Dyslipidemia
Consumption of olive oil polyphenols contributes to the
protection of LDL particles from oxidative damage ´ The Panel concludes that a cause and effect relationship has been
established between the consumption of olive oil polyphenols (standardized by their content of hydroxytyrosol and its derivatives) and protection of LDL particles from oxidative damage.
´ The Panel considers that in order to bear the claim, 5 mg of hydroxytyrosol and its derivatives (e.g. oleuropein complex and tyrosol) should be consumed daily.
Tensiofytol Mode of action Focus on an endothelial cell :
Oleuropein Hydroxytyrosol
OXIDATIVE STRESS
en
do
the
lial c
ell
CAPTION: § O2 : Superoxide § NO : Nitric Oxide § eNOS : Endothelial Nitric Oxide Synthase § ONOO- : Peroxynitrite
smooth muscle IMPROVES THE
OF THE WALL
ENDOTHELIAL FUNCTION AND THE FLEXIBILITY
Oleuropein/Hydroxytyrosol : DOUBLE ACTION : diminishes the destruction of NO & increases the production of NO :
Endothelial reactivity2 Flexibility of blood vessels2
1. Hypertension & endothelial dysfunction 2. Tensiofytol® : composition & MOA 3. Metabolic syndrome 4. Efficacy studies 5. PREDIMED study 6. Patient’s profile & ongoing study
↓ insulin signalling (PIP3 – PKB/Akt)
↓ GLUT4 translocation
muscle insulin resistance
Atherogenic dyslipidemia
hepatic insulin resistance
↑ apoB-VLDL-TG lipoproteins
IFG-IGT / T2DM in predisposed individuals
hepatic lipogenesis
NAFL, NAFLD, NASH
Proinflammatory state
↓ glucose transport and uptake
↓ glycogen synthesis
↑ IR-inducing secretory products and NEFAs; ↓ adiponectin
↑ glucose output
chronic hyperinsulinaemia
Fatty tissue expansion
adipocyte dysregulation
Selective IR & hyperinsulinemia
hepatocyte HGO & hyperglycemia Steatosis and VLDL export
vascular endotheliocyte Decreased NO Increased endothelin
muscle insulin resistance
genetic &/or acquired mitochondrial defects (density/function/biogenesis)
↓ oxidation capacity: sarcopenia, fiber type & distribution, ageing, obesity
Atherogenic dyslipidemia
hepatic insulin resistance
↑ apoB-VLDL-TG lipoproteins
IFG-IGT / T2DM in predisposed individuals
hepatic lipogenesis
NAFL, NAFLD, NASH
Proinflammatory state
↑ IR-inducing secretory products and NEFAs; ↓ adiponectin
↑ glucose output
chronic hyperinsulinaemia
Nutritional-physical activity imbalance
adipocyte dysregulation
� � �
�
�
1. Hypertension & endothelial dysfunction 2. Tensiofytol® : composition & MOA 3. Metabolic syndrome 4. Efficacy studies 5. PREDIMED study 6. Patient’s profile & ongoing study
Double blind cross-over on 24 women, 1st diagnostic
11 women, prehypertension: SBP 120 – 139 mmHg and/or DBP 80-89 mmHg
13 women, mild hypertension: SBP140-159 mmHg and/or DBP 90-99 mmHg
Baseline after 4 months Mediterranean diet: Average Systolic Blood Pressure (SBP) 134,1 mmHg, average Diastolic Blood Pressure (DBP) 84.6 mmHg
Treatment: virgin olive oil (VOO) vs. Placebo (olive oil without polyphenols)
VOO: 60ml oil à 30 mg total polyphenols /day
Duration: 2 months treatment – 1 month wash out – Switch – 2 months treatment
Olive oil polyphenols decrease blood pressure and improve endothelial function in young women with mild hypertension. Moreno-luna et al. Am. J. Hypertension , dec. 2012 ,
Efficiency + Mode of action
SBP= Systolic Blood Pressure DBP=Diastolic Blood Pressure Moreno-luna et al. Am. J. Hypertension , dec. 2012 ,
Baseline after 4 months Mediterranean diet: Average Systolic Blood Pressure (SBP) 134,1 mmHg, average Diastolic Blood Pressure (DBP) 84.6 mmHg
Results
1. Decrease SBP: -7,9 mmHg and DBP -6,7 mmHg, p< 0.01 vs. Baseline
2. Ox- LDL = - 28 μg/L p < 0.01
3. CRP = - 1.9 mg/l p < 0.001
4. Improvement of endothelial function; flexibility of the blood vessel wall. p < 0.001
´ Increase in NO metabolites
Olive oil polyphenols decrease blood pressure and improve endothelial function in young women with mild hypertension. Moreno-luna et al. Am. J. Hypertension , dec. 2012 ,
60ml VOO(30mg Polyphenols): 134.1mmHg à 126.2mmHg – 7.9mmHg p< 0.01
Efficiency + Mode of action
Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension:
Comparison with Captopril
Olive leaf extract Susalit 2011 Phytomedicine 18 (2011) 251–258
´ Double blind study, olive leaf extract vs. Antihypertensive
´ N=162 (148 evaluated), Patients with mild Hypertension (stage 1) SBP 140-159 mmHg
´ Baseline average SBP: 149.3 ±5.58mmHg group olive leaf extract and 148.4 ±5.56mmHg group Captopril; Baseline average DBP: 93.9 ±4.51and 93.8 ±4.88mmHg respectively
´ Treatment:
500 mg leaf extract à 100 mg oleuropein (OE) 2x/d vs. 12.5 – 25mg Captopril 2x/d.
´ Captopril: the 1st inhibitor of angiotensin-converting enzyme (ACE)
´ Duration: 2 months
Efficiency
Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension:
Comparison with Captopril
Olive leaf extract Susalit 2011 Phytomedicine 18 (2011) 251–258
Results:
´ Decrease SBP/DBP= −11.5 / -4.8 mmHg with olive leaf extract
´ -13.7/-6.4 mmHg with Captopril
´ As efficient as Captopril (50mg/day) on the decrease of SBP and DBP
´ Significant reduction of triglycerides: -23% (p<0.01)
´ No effect on the triglycerides in the group of Captopril
1000mg OLE (200 OE): 149mmHg à 137.8 mmHg – 11.5mmHg
Efficiency
Results – Blood pressure
-35 %
Ischemic heart disease
Lethal Cerebrovascular accident
-50 %
No statistical difference measured on the side effects between the treated group and placebo
1x/day N=50 patients with metabolic syndrome
Efficiency 10mg Hydroxytyrosol
Systolic Blood Pressure (mmHg)
Diastolic Blood Pressure (mmHg)
> Decrease of the cardiovascular risk LLewington S et al., Lancet. 2002;360:1903-1913
Meta-analysis on 61 observational studies (on 1 million adult patients)
7%
Decrease of 2 mmHg Coronary artery disease Systolic Blood pressure
10% Decrease of mortality due to a stroke
Randomized studies on elderly subjects with hypertension and treated since at least 5 years with beta blockers and diuretics N =62 : 31 Hypertensive + 31 Normotensive / 42 women 20 men Average age 84 years Treatment: 60g/day Virgin olive oil (VOO) vs. Sunflower oil Duration: 1 month treatment – 1 month wash out – Switch – 1 month treatment
Olive oil, in combination with antihypertensive drugs Perona 2004 Clinical Nutrition (2004)
Virgin olive oil reduces blood pressure in hypertensive elderly subjects
Efficiency
Results: Virgin olive oil (VOO), reduces the BP and normalizes the BP (136 mmHg) vs. Sunflower oil (150 ±8 mmHg). Virgin olive oil (VOO) reduced the total Cholesterol and the LDL-Cholesterol in the Normotensive patients (P<0:01) vs. Sunflower oil
Olive oil, in combination with antihypertensive drugs
Perona 2004 Clinical Nutrition (2004)
Virgin olive oil reduces blood pressure in hypertensive elderly subjects
VOO: 150 mmHg à 136 mmHg – 14mmHg P<0.01 vs Sunflower oil
VOO: Virgin Olive Oil SO: Sunflower oil
SIGNIFICANT ACTION ON THE BLOOD PRESSURE IN ADDITION TO AN ANTIHYPERTENSIVE TREATMENT!
Efficiency
NT: Normotensive HT: Hypertensive
1. Hypertension & endothelial dysfunction 2. Tensiofytol® : composition & MOA 3. Metabolic syndrome 4. Efficacy studies 5. PREDIMED & Mediterranean diet 6. Patient’s profile & ongoing study
PREDIMED STUDY LONG-TERM EFFECT Prevention
7447 subjects during 4,8 years a. Mediterranean diet + Virgin olive oil: 1 liter/week b. Mediterranean diet + Nuts: 30g/ day (walnuts, hazelnuts, almonds) c. Control: low fat diet
PREDIMED Study : 7447 subjects have followed one of these 3 diets during 4,8 years9
Number of myocardial infarctions, strokes and deaths due to cardiovascular causes :
Inc
ide
nce
of t
he c
ard
iova
scul
ar e
vent
s -30% cardiovascular events (p<0,003)
Control group Mediterranean diet + nuts Mediterranean diet + Extra Virgin olive oil
Years
The Mediterranean diet caused reductions in oxidized LDL cholesterol, along with improvements in several other heart disease risk factors
Effect of a Traditional Mediterranean Diet on Lipoprotein Oxidation. JAMA Internal Medicine, 2007.
372 individuals from the PREDIMED study who were at a high cardiovascular risk were assessed after 3 months
VOO: Virgin Olive Oil
1 year intervention with two Mediterranean diets (Med-diet) could decrease blood pressure (BP) due to a high polyphenol consumption N= 200 high CV risk (elderly) 1 year EVOO vs. Med-nuts / randomized controlled clinical trial Measure: BP, NO, Total Polyphenol Excretion (TPE) Systolic and diastolic BP decreased significantly after a one-year dietary intervention with Med-EVOO and Med-nuts. These changes were associated with a significant increase in TPE and plasma NO. Additionally, a significant positive correlation was observed between changes in urinary TPE, a biomarker of TP intake, and in plasma NO.
Olive oil Medina Remon 2015
Effects of total dietary polyphenols on plasma nitric oxide and blood pressure in a high cardiovascular risk cohort.
The PREDIMED randomized trial
This was a three-arm randomized trial in 418 non-diabetic subjects aged 55–80 years recruited in one center Participants were randomly assigned to education on a low-fat diet (control group) or to one of two MedDiets, supplemented with either free virgin olive oil (1 liter/week) or nuts (30 g/day), for 4 years
diabetes incidence reduced by 52%
Hydroxytyrosol Reduction in Incidence of T2DM with Mediterranean Diet Results of the PREDIMED-Reus nutrition intervention randomized trial
A = olive oil C = control
P<0.047
Action olive oil : Inflammation Marker and Endothelial Function
• 30 studies / 3106 patients § Dosage: 1 – 50 mg /day • ê significant CRP (C-Reactive Protein)(p<0.0001) n=15 studies • ê significant IL-6 (Interleukin-6) (p<0.04 • Improvement of the endothelial function (NO)/ (p<0.002) n=8
• é flow-mediated dilation(FMD )
Olive oil exerts beneficial effects on the endothelial functions and on the inflammation markers à contributes to the cardiovascular protection linked to the Mediterranean diet
Meta-analyse – Olive oil Schwingshackl 2015 nutrients Effects of Olive Oil on Markers of Inflammation and Endothelial
Function—A Systematic Review and Meta-Analysis
Mode of action
• Improvement of the endothelial function (NO)/ n=8 studies 335 patients • é flow-mediated dilation (FMD) p<0.002
Meta-analyse – Olive oil Schwingshackl 2015 nutrients Effects of Olive Oil on Markers of Inflammation and Endothelial
Function—A Systematic Review and Meta-Analysis
Mode of action
1. Hypertension & endothelial dysfunction 2. Tensiofytol® : composition & MOA 3. Metabolic syndrome 4. Efficacy studies 5. PREDIMED study 6. Patient’s profile & ongoing study
Tensiofytol vs. Antihypertensive drugs
+ Action on the other risk factors:
Triglycerides, oxLDL, HDL, glycemia (glucose
intolerance)
Profiles of patients at risk?
> 45 years > 50 years
Regular BP > 130/80 mmHg In pre- or post-menopause
n Family history of hypertension n high cholesterol level n Overweight n Sedentary n Keen on salt - prepared dishes
n Metabolic syndrome
To whom advice early natural medical care? Measure the BP (mmHg)
Optimal BP Pre-hypertension Normal HT HT stage 1
Prevention advice
Control 1/year
Symptomatic Asymptomatic Symptomatic
Lifestyle
Control every 6 months Check regularly
Study of associated CVRF + evaluation of complications
Medical evaluation
Study of associated CVRF + evaluation of complications +
Etiology
Pharmacological
treatment
Dietary supplement targeted standardized at :
n 100 mg oleuropein
n 20 mg hydroxytyrosol
Dietary supplement targeted*
standardized at :
n 100 mg oleuropein
n 20 mg hydroxytyrosol
*If the targeted blood pressure remains difficult to reach with the pharmacologocal treatment and lifestyle
EndoPat 2000, Itamar
Reactive Ischemia Hyperemia (RIH)
Morten and Vidiendal Olsen Evaluation of endothelial function by peripheral arterial tonometry and relation with the nitric oxide pathway. Nitric Oxide 2014
Left arm
Right arm
6 minutes rest 5 minutes of ischemia
6 minutes post ischemia
EndoPat 2000 system
2 caps (100 mg oleuropéine
20 mg hydroxytyrosol)
T0 T 1 hour
On going study at ULG/Cardio service : vasodilating effect of Tensiofytol evaluated with the EndoPat